Konstantina Skourti-Stathaki leads the n-Lorem research team behind the design and discovery of ASOs. Nadina, as we at n-Lorem call her, has a passion for helping patients and an excitement for science that is contagious. She joins the Patient Empowerment Program podcast to discuss her day-to-day activities as n-Lorem’s Director of ASO Design and Discovery, the ongoing research her team is conducting, and more!
On This Episode We Discuss:
<ul><li>Inspired to study biology at the University of Crete</li>
<li>Leaving Greece to attend grad school at the University of Oxford</li>
<li>An internship led Nadina to the world of RNA</li>
<li>Leaving academia to impact lives</li>
<li>Lessons learned from experiencing drug discovery and development</li>
<li>The reason she joined n-Lorem</li>
<li>Day-to-day activities as Director of ASO Design and discovery</li>
<li>n-Lorem’s internal research management committee to make key decisions regarding programs</li>
<li>Ongoing research at n-Lorem to enhance allele selectivity</li>
<li>Stan Crooke on why he pioneered antisense technology</li>
</ul>

Konstantina Skourti-Stathaki leads the n-Lorem research team behind the design and discovery of ASOs. Nadina, as we at n-Lorem call her, has a passion for helping patients and an excitement for science that is contagious. She joins the Patient Empowerment Program podcast to discuss her day-to-day activities as n-Lorem’s Director of ASO Design and Discovery, the ongoing research her team is conducting, and more! On This Episode We Discuss: Inspired to study biology at the University of Crete Leaving Greece to attend grad school at the University of Oxford An internship led Nadina to the world of RNA Leaving academia to impact lives Lessons learned from experiencing drug discovery and development The reason she joined n-Lorem Day-to-day activities as Director of ASO Design and discovery n-Lorem’s internal research management committee to make key decisions regarding programs Ongoing research at n-Lorem to enhance allele selectivity Stan Crooke on why he pioneered antisense technology

Behind the ASO Design and Discovery with Konstantina Skourti-Stathaki, Ph.D.

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. 

n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. 

The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.

Science

Medicine

Health & Fitness

Education

Life Sciences

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.

Share Behind the ASO Design and Discovery with Konstantina Skourti-Stathaki, Ph.D.

Sign up to save your podcasts

Behind the ASO Design and Discovery with Konstantina Skourti-Stathaki, Ph.D.

Behind the ASO Design and Discovery with Konstantina Skourti-Stathaki, Ph.D.

More shows like Patient Empowerment Program: A Rare Disease Podcast

This American Life

Embedded

The Daily

Crime Junkie

The Readout Loud

The Weekly Show with Jon Stewart

BioSpace